Canada’s medical cannabis market began as a flower-only market, but, following a court ruling, the licensed producers (LPs) were permitted to begin producing extracts in late 2015. While these products...
In late May, Lift hosted its first Cannabis Business Conference in Toronto. It was a fantastic event that included many thought leaders in North America and covered eight timely and important...
Emerald Health and Village Farms Announce Strategic Venture to Leverage Large-Scale Greenhouse Infrastructure and Cannabis Production Expertise Transformational combination of expert medicinal cannabis grower with a leading North American...
While Health Canada, which provided an update on April 24th, continues to get the official data out to the public very slowly, the patient enrollment growth in the ACMPR...
The first week of trading for the new Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) (OTC: HMLSF) has been a tremendous success. While Tuesday saw its first decline...
Emerald Health Announces Increase in Bought Deal to $24.4 Million VICTORIA, BRITISH COLUMBIA–(Marketwired – April 11, 2017) – Emerald Health Therapeutics Inc. (TSXV: EMH) (OTC: TBQBF) (“Emerald” or the...
Let’s face it, when it comes to cannabis stocks, Canada continues to crush the United States, where federal illegality makes it more difficult to operate and to raise capital....
Emerald Provides Corporate Update and Lays out 2017 Growth Initiatives VICTORIA, Feb. 22, 2017 /CNW/ – Emerald Health Therapeutics Inc. (TSXV: EMH) (OTC: TBQBF) ((“Emerald” or the “Company”) provides...
After a boom in the stock prices of Canadian licensed producers (LPs) in 2016 that left the average stock up more than 355%, the sector is performing very well...
Emerald Announces Closing of $13.8 Million Bought Deal VICTORIA, Feb. 10, 2017 /CNW/ – Emerald Health Therapeutics Inc. (TSXV: EMH) (“Emerald” or the “Company”) is pleased to announce the closing...
Statement from Health Canada on the Testing of Cannabis for Medical Purposes for Unauthorized Pest Control Products OTTAWA, Feb. 7, 2017 /CNW/ – Recently, two licensed producers of cannabis...
Canadian licensed producer Emerald Health (TSXV: EMH) (OTC: TBQBF) announced a bought deal to raise $10mm by selling 7.408mm Units at $1.35 consisting of common shares and a warrant...
Blogger Marc Davis profiled Emerald Health (TSXV: EMH) (OTC: TBQBF) recently, discussing the strategy of its Executive Chairman, Dr. Avtar Dhillon, who is building a business focused on medical...
Perhaps the biggest story of 2016 in the cannabis capital markets was the surge in prices and the amount of capital raised for the cannabis industry in Canada during...
Emerald Health Launches Cannabis Oil VICTORIA, Sept. 22, 2016 /CNW/ – Emerald Health Therapeutics Inc. (TSXV: EMH) (“Therapeutics”) is pleased to announced that its wholly owned subsidiary, Emerald Health...
When Justin Trudeau and the Liberal Party won a majority of seats in the Canadian Parliament elections in October last year, it set off a quick pop in the...
Despite a rapidly growing underlying industry, investors in the publicly-traded cannabis stocks have been dodging landmines for several years now, with few companies producing solid returns so far and...
